Ann: Zelda to merge with US-based Ilera Therapeutics, page-143

I agree with you. though I see both sides of the story for me it was more logically for this small business to merge with a bigger firm that has more exposure. cannabis firms are popping up left right and centre. when their is so much competition , to survive sometimes even if you believe your product is better you have to just do this to stay in the game. yes looks too soon especially when the results from the trials are coming out soo . but there must have been a rational reason why they had to do this now. we don't know what the commercial terms were when ilera came into the picture. maybe Zeldas plan was always to merge but there was commercial milestone conditions that had to be met.

technically Zelda is small fish. yes they got these clinical trials coming up but across the world small firms like Zelda are all doing the same. these guys are trying to future proof the business. that's all.it looks like a crappy move but will it matter in 2-5 years the business is making revenue regardless of who owns what? the end investor will reap the rewards of this company generating revenue in both hemisphere. I am looking forward to see their move in europe.

that is my 2 cents. I will probably get blasted for this =)